Plasma antipyrine half-life can be determined from urine data. 1987

J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke

Antipyrine half-life has been determined from measurements of antipyrine concentrations in spontaneously voided urine specimens in eleven subjects, studied on a total of forty-seven different occasions while receiving no drugs, interferon or ketoconazole. Plasma and saliva half-lives show good intrasubject correlation. Plasma and urine half-lives show good intrasubject correlation provided total urine output is at least 1.1 l day-1. The range of intrasubject correlation coefficients for plasma and urinary half-lives was 0.76 to 0.98, with a median value of 0.85. Saliva and urine half-lives show good intrasubject correlation, with the range of intrasubject correlation coefficients from 0.74 to 0.98, and with a median value of 0.75. There is a small but consistent bias towards shorter urinary half-life estimates; this averaged 0.75 h for the plasma-urine studies and 0.192 h for the saliva-urine studies. There were parallel changes in antipyrine half-life estimated from plasma and urine for one of our subjects who received multiple doses of recombinant beta-interferon and had a 150% increase in antipyrine half-life over the study period.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone

Related Publications

J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
February 1977, British medical journal,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
January 1980, Cancer chemotherapy and pharmacology,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
December 1978, Gan,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
January 1973, Pharmacology,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
May 1985, Oecologia,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
April 1981, East African medical journal,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
February 1973, British journal of pharmacology,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
October 1984, British journal of clinical pharmacology,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
January 1987, European journal of clinical pharmacology,
J O Atiba, and G Taylor, and R A Pershe, and T F Blaschke
January 1980, Clinical pharmacokinetics,
Copied contents to your clipboard!